ca199 | 25423
CA19-9
Keywords
5-FU tolerance (DPD gene), ca199, Cancer, gastrointestinal, Malignoma, ovary, Pancreas, Tumor, Tumor marker
| Material |
|
|
| Note |
No measurable CA 19-9 increases are expected in patients with the rare Lewis a-b- blood group (in 3-7% of the population), as they lack a sialyltransferase important for CA 19-9 epitope expression and a fucosylated precursor chain. |
|
| Min. quantity | 500 µL | |
| Stability | 2 days / 2-8°C; 3 months / -20°C | |
| Duration | 2 hours | |
| Frequency | 6 x a week, 24/7 in case of emergency | |
| Method | Chemiluminescent Immuno Assay | |
| Price | CHF 21.60 | |
| Tariff | 21.60 TP | |
| LA position | 1218.00 | |
| Designation | CA 19-9 |
Team of consultants
|
Dr. rer. nat.
Kristina Vollmer
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
MD
Uta Deus
Specialist in General Internal Medicine, FAMH Specialist in laboratory medicine, main field clinical chemistry
|
Specialist in General Internal Medicine, FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology
|
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology | T |
|
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|